Oaktree Acquisition Corp. III Life Sciences (OACC) Non-Current Assets (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Non-Current Assets readings, the most recent being $203.4 million for Q1 2026.

  • Quarterly Non-Current Assets rose 3.91% to $203.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $802.4 million through Mar 2026, changed N/A year-over-year, with the annual reading at $201.6 million for FY2025, 4.06% up from the prior year.
  • Non-Current Assets hit $203.4 million in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $201.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $203.4 million in Q1 2026 and bottomed at $193.7 million in Q4 2024.
  • Average Non-Current Assets over 3 years is $198.6 million, with a median of $198.7 million recorded in 2025.
  • The largest annual shift saw Non-Current Assets rose 4.06% in 2025 before it grew 3.91% in 2026.
  • Oaktree Acquisition Corp. III Life Sciences' Non-Current Assets stood at $193.7 million in 2024, then grew by 4.06% to $201.6 million in 2025, then rose by 0.92% to $203.4 million in 2026.
  • Per Business Quant, the three most recent readings for OACC's Non-Current Assets are $203.4 million (Q1 2026), $201.6 million (Q4 2025), and $199.8 million (Q3 2025).